These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32044685)

  • 1. Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report.
    Yamashita Y; Ogawa T; Ogaki K; Kamo H; Sukigara T; Kitahara E; Izawa N; Iwamuro H; Oyama G; Kamagata K; Hatano T; Umemura A; Kosaki R; Kubota M; Shimo Y; Hattori N
    J Neurol Sci; 2020 Apr; 411():116710. PubMed ID: 32044685
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation.
    Kulkarni N; Tang S; Bhardwaj R; Bernes S; Grebe TA
    J Child Neurol; 2016 Feb; 31(2):211-4. PubMed ID: 26060304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of severe movement disorder with GNAO1 mutation responsive to topiramate.
    Sakamoto S; Monden Y; Fukai R; Miyake N; Saito H; Miyauchi A; Matsumoto A; Nagashima M; Osaka H; Matsumoto N; Yamagata T
    Brain Dev; 2017 May; 39(5):439-443. PubMed ID: 27916449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent response to deep brain stimulation in a young girl with GNAO1-related progressive choreoathetosis.
    Yilmaz S; Turhan T; Ceylaner S; Gökben S; Tekgul H; Serdaroglu G
    Childs Nerv Syst; 2016 Sep; 32(9):1567-8. PubMed ID: 27278281
    [No Abstract]   [Full Text] [Related]  

  • 5. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.
    Koy A; Cirak S; Gonzalez V; Becker K; Roujeau T; Milesi C; Baleine J; Cambonie G; Boularan A; Greco F; Perrigault PF; Cances C; Dorison N; Doummar D; Roubertie A; Beroud C; Körber F; Stüve B; Waltz S; Mignot C; Nava C; Maarouf M; Coubes P; Cif L
    J Neurol Sci; 2018 Aug; 391():31-39. PubMed ID: 30103967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation.
    Miyamoto S; Nakashima M; Fukumura S; Kumada S; Saitsu H
    Neurogenetics; 2022 Apr; 23(2):129-135. PubMed ID: 35147852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS.
    Waak M; Mohammad SS; Coman D; Sinclair K; Copeland L; Silburn P; Coyne T; McGill J; O'Regan M; Selway R; Symonds J; Grattan-Smith P; Lin JP; Dale RC; Malone S
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):221-222. PubMed ID: 28668776
    [No Abstract]   [Full Text] [Related]  

  • 8. Mice with
    Larrivee CL; Feng H; Quinn JA; Shaw VS; Leipprandt JR; Demireva EY; Xie H; Neubig RR
    J Pharmacol Exp Ther; 2020 Apr; 373(1):24-33. PubMed ID: 31907305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNAO1 Mutation-Induced Pediatric Dystonic Storm Rescue With Pallidal Deep Brain Stimulation.
    Honey CM; Malhotra AK; Tarailo-Graovac M; van Karnebeek CDM; Horvath G; Sulistyanto A
    J Child Neurol; 2018 May; 33(6):413-416. PubMed ID: 29661126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation and treatment effects in young patients with
    Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic review on GNAO1-associated movement disorder.
    Feng H; Khalil S; Neubig RR; Sidiropoulos C
    Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
    Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
    Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
    Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
    J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
    Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
    Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epileptic encephalopathy, movement disorder, and the yin and yang of
    Pearson TS; Helbig I
    Neurology; 2017 Aug; 89(8):754-755. PubMed ID: 28747451
    [No Abstract]   [Full Text] [Related]  

  • 16. GNAO1 Haploinsufficiency: The Milder End of the GNAO1 Phenotypic Spectrum.
    Galosi S; Novelli M; Di Rocco M; Flex E; Messina E; Pollini L; Parrini E; Pisani F; Guerrini R; Leuzzi V; Martinelli S
    Mov Disord; 2023 Dec; 38(12):2313-2314. PubMed ID: 37632268
    [No Abstract]   [Full Text] [Related]  

  • 17. AAV9-Mediated Intrastriatal Delivery of
    Roy AJ; Leipprandt JR; Patterson JR; Stoll AC; Kemp CJ; Oula ZD; Mola T; Batista AR; Sortwell CE; Sena-Esteves M; Neubig RR
    J Pharmacol Exp Ther; 2024 Jul; 390(2):250-259. PubMed ID: 38866563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.
    Feng H; Larrivee CL; Demireva EY; Xie H; Leipprandt JR; Neubig RR
    PLoS One; 2019; 14(1):e0211066. PubMed ID: 30682176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder.
    Ananth AL; Robichaux-Viehoever A; Kim YM; Hanson-Kahn A; Cox R; Enns GM; Strober J; Willing M; Schlaggar BL; Wu YW; Bernstein JA
    Pediatr Neurol; 2016 Jun; 59():81-4. PubMed ID: 27068059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorder in
    Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
    Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.